Non-Antibiotics
| Product |
Pharmacopeia |
DMF availability |
COS |
| Aripiprazole |
In-house |
√ |
- |
| Armodafinil |
In-house |
√ |
- |
| Dexlansoprazole |
In-house |
√ |
- |
| Duloxetine Hydrochloride |
In-house |
√ |
- |
| Eszopiclone |
In-house |
√ |
- |
| Felodipine |
USP / EP/BP |
√ |
- |
| Granisetron Hydrochloride |
EP/BP |
√ |
√ |
| Ibandronate Sodium |
In-house |
√ |
- |
| Levetiracetam |
USP/EP |
√ |
- |
| Memantine Hydrochloride |
In-house |
√ |
- |
| Modafinil |
USP / EP |
√ |
√ |
| Naratriptan Hydrochloride |
USP |
√ |
- |
| Nisoldipine |
In-house |
√ |
- |
| Paliperidone |
JP |
√ |
- |
| Phenytoin Sodium |
USP/EP/BP |
√ |
- |
| Pramipexole Dihydrochloride |
EP |
√ |
- |
| Quetiapine Fumarate |
USP/EP |
√ |
- |
| Rabeprazole Sodium |
In-house |
√ |
- |
| Rasagiline Mesylate |
In-house |
√ |
- |
| Rivastigmine Tartrate |
In-house |
√ |
- |
| Ropinirole Hydrochloride |
In-house |
√ |
- |
| Sumatriptan Succinate |
USP /EP/BP |
√ |
√ |
| Tadalafil |
In-house |
√ |
- |
| Telmisartan |
USP / EP |
√ |
- |
| Terbinafine Hydrochloride |
USP / EP/BP |
√ |
√ |
| Tolterodine Tartrate |
In-house |
√ |
- |
| Zaleplon |
USP |
√ |
- |
| Zolmitriptan |
In-house |
√ |
- |
Disclaimer
Product exploitation, including development, sales and offer for sale are performed where permissible by patent law. This presentation is not and should not constitute as an offer for sales in territories where it is not permitted by law.